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Chronic consumption of a high-fat diet is a lifestyle factor that increases the risk for 
cognitive impairment (Granholm et al., 2008; Greenwood & Winocur, 2005; Mattson, 2004; 
Winocur & Greenwood, 2005). A high-fat diet appears to facilitate cognitive impairment through 
the promotion of insulin resistance (Greenwood & Winocur, 2005; Stranahan et al., 2008; Winocur 
& Greenwood, 2005). A gap in the literature is an established timeframe of the progression and 
underlying mechanism, which study in animals would better afford. Furthermore, A limited 
number of studies have investigated the relationship between a high-fat diet and behavioral 
dysregulation such as anxiety and depression. The 1st aim of the study was to determine if 
consumption of a high-fat diet leads to cognitive impairment and behavioral dysfunction at 3, 8, 
or 13 weeks of consumption. The 2nd aim was to determine if cholesterol levels and HBP activity 
are aberrantly increased in specific regions in mice that display feeding induced 
cognitive/behavioral dysfunction. Consumption of the experimental specialty diets produced a 
number of significant behavioral effects. These significant effects began to emerge after only 3 
weeks of low-and high-fat feeding with increased anxiety-like behavior displayed higher in the 
high-fat diet group for the Elevated Plus Maze and Open Field Test. There was increased 
thigmotactic behavior and floating in the low-fat diet group in the Morris Water Maze (MWM) 
task, therefore making cognitive assessment uninterpretable. This pattern in the behavioral tasks 
were more robust in the 8 week group and alleviated in the 13 week group. There was only a 
significant difference in depression-like symptoms in the Forced Swim (FS) Task in the 3 week 
group. Cholesterol analysis is still under review in Dr. Elmendorf’s lab to correlate cholesterol 
levels and cognitive/behavioral impairment. 
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CHAPTER 1 INTRODUCTION 
1.1 Lifestyle Impact on Brain Function 
Chronic consumption of a high-fat diet is a lifestyle factor that increases the risk for 
cognitive impairment (Granholm et al., 2008; Greenwood & Winocur, 2005; Mattson, 2004; 
Winocur & Greenwood, 2005). A high-fat diet consists of saturated fats, hydrogenated fats and 
refined carbohydrates (Granholm et al., 2008; Kaplan & Greenwood, 1998). A high-fat diet 
appears to facilitate cognitive impairment through the promotion of insulin resistance (Greenwood 
& Winocur, 2005; Stranahan et al., 2008; Winocur & Greenwood, 2005).  
This relationship was founded in Alzheimer Disease (AD) research investigating early 
modifiable risk factors such as insulin resistance and Type 2 diabetes (T2D) (Kilander, Nyman, 
Boberg, Hansson, & Lithell, 1998; Muller et al., 2007; Nazaribadie et al., 2013; Rasgon et al., 
2011; Ronnemaa et al., 2008; Schrijvers et al., 2010; Yaffe, Blackwell, Kanaya, Davidowitz, 
Barrett-Connor & Krueger, 2004; Young, Mainous, & Carnemolla, 2006). Insulin resistance is 
associated with a reduced glucose metabolic rate and subtle cognitive impairment with early stages 
of T2D (Janson et al., 2004). Advanced stages of insulin resistance are associated with greater 
hippocampal and amygdalar atrophy in T2D patients, which have been associated with lower 
verbal memory performance in elderly patients (den Heijer et al., 2003). The development of 
insulin resistance starts years before diagnosis of T2D, and even before prediabetes (Mason, 
Hanson, & Knowler, 2007; Tabak et al., 2009; Weyer, Bogardus, Mott, & Pratley, 1999). 
Moreover, cognitive and related affective behavior decline are widely observed in prediabetes and 
T2D patients, suggesting insulin resistance or an accompanying metabolic derangement may be 
responsible for an increased risk of AD (Kilander, Nyman, Boberg, Hansson, & Lithell, 1998; 
Muller et al., 2007; Nazaribadie et al., 2013; Rasgon et al., 2011; Ronnemaa et al., 2008; Schrijvers 
et al., 2010; Yaffe, Blackwell, Kanaya, Davidowitz, Barrett-Connor & Krueger, 2004; Young, 
Mainous, & Carnemolla, 2006). 
Cell data demonstrate that conditions that mimic the high-fat feeding milieu stimulate 
cholesterol biosynthesis via increasing hexosamine biosynthesis pathway (HBP) activity 
(Bhonagiri et al., 2011, Habegger et al., 2012, Penque et al., 2013). Unpublished in vivo data 
support these cell data showing that in the setting of high-fat feeding peripheral tissue (muscle, 
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fat) and brain (cerebrum) cholesterol levels are increased. Emerging evidence suggests that 
deregulated cholesterol metabolism in the peripheral nervous system may be coupled to and/or a 
determinant of the development of insulin resistance (Stranahan et al., 2008; Winocur & 
Greenwood, 2005). The changes in the peripheral nervous system have also been implicated in 
elevation in brain cholesterol that is important for cognitive processing. The underlying 
relationship between high-fat diet induced changes in peripheral and brain cholesterol remains 
unknown.  
Since World War II, western society has seen a trend in the overconsumption of diets 
containing excess fat (Granholm et al., 2008). Of growing concern is that a history of high-fat diet 
consumption has been associated with behavioral dysregulation (Gainey et al., 2016; Sharma, 
Fernandes, & Fulton, 2013). All in all, investigating the behavioral and underlying biological 
mechanism(s) associated with high-fat consumption will be essential to understanding risk factors 
associated with prediabetes, T2D, cognitive decline, and perhaps even AD. 
1.2 High-Fat Diet & Cognitive Impairment 
Cross-sectional and longitudinal studies indicate that high-fat consumption in various age 
groups leads to cognitive impairment (Eskelinen et al., 2008; Kalmijn et al., 2004; Kanoski & 
Davidson, 2011; Solfrizzi, Panza, & Capurso, 2003). A study by Eskelinen et al. (2008) 
investigated the relationship between midlife dietary fat intake and cognitive impairment. Their 
design was a longitudinal population-based study in which samples were collected at midlife 
(50.2), and an average follow-up was 21 years (71.1). They found that saturated fat (SFA) intake 
(milk products & butter) were associated with poorer global cognitive function and prospective 
memory.  
Other studies have experimentally manipulated dietary fat and examined the effects on 
cognition. Two studies looked at young males that controlled their diets and measured the effects 
on cognition (Beilharz, Maniam, & Morris, 2015; Morris, Beilharz, Maniam, Reichelt, & 
Westbrook, 2015). Holloway et al. (2011) investigated the effects of a high-fat diet (75% Fat) to 
see if any alterations occurred in healthy subjects. Male subjects (n=16) were randomly assigned 
for five days to consume either the high-fat diet (75% Fat) or a standard diet (23% Fat). It was a 
crossover design, so after a 2-week washout period, subjects consumed the opposite diet. A 
nutritionist educated the subjects on healthy eating and developed a prospective food diary that 
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started 3 days prior to testing. Each subject was required to follow the prescribed meal plans. A 
post-hoc dietary analysis was done using a computer-based program. In order to assess cognitive 
function, the individuals did the Cognitive Drug Research (CDR) computerized assessment battery 
to measure attention and episodic memory, as well as a self-report to evaluate their mood and 
alertness. They also conducted a Rapid Visual Information Processing (RVIP) task that assessed 
complex attention and working memory. It was found that consuming the high-fat diet for five 
days impaired attention and speed of retrieval, as well as depressed the subjects’ mood (Holloway 
et al., 2011).  
A similar study using sedentary male subjects (i.e., physical exertion less than 2 hrs. in a 
week) revealed a detrimental cognitive effect of inactivity. In this study, the subjects were given a 
balanced diet for 3 days, and then switched to either a high-fat diet (74%) or a standard diet (17.2%) 
for 7 days. A written dietary plan was given to them, each subject recorded the food consumed 
each day and had an ongoing phone interview to monitor compliance. A post hoc dietary analysis 
was done to confirm compliance. To assess cognitive functions, they were given the CDR 
computerized assessment battery to measure attention, episodic memory, and two self-reports to 
measure mood and alertness. They also conducted a RVIP task that assessed complex attention 
and working memory. As a result, there was a decrease in reaction time and attention (Edwards et 
al., 2011).  
Finally, a recent study in prepubertal children related saturated fats and dietary cholesterol 
to cognitive flexibility (Khan, Raine, Drollette, Scudder & Hillman, 2015). The children between 
ages 7-10 were assessed by a dietician for dietary intake in a 24-hour food recall with parental 
help. Using the Color-Shape Task Switching Paradigm, which utilizes visuospatial attention and 
reaction time to determine cognitive flexibility, assessment of cognition was made. As a result, 
they did a partial correlation between diet variables and switch task performance (adjusting for 
age, sex, SES, VO2 max, and BMI).  The study demonstrated that the saturated fats and dietary 
cholesterol decreased affected their cognitive flexibility (Khan et al., 2015). Collectively, these 
data from these studies provide strong human evidence that high-fat diet negatively impacts 
cognition. 
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1.3 High-Fat Diet & Animal Models 
In strong agreement with the clinical data, high-fat feeding of animals has been 
demonstrated to impair cognition. A significant gap, however, in our understanding is an 
established timeframe of the progression and underlying mechanisms, which study in animals 
would better afford. Therefore, the utilization of animal models to measure the progressive effects 
of high-fat feeding on cognition and behavior would be of translational value to advancing 
understanding human brain disorders. Moreover, parallel cellular/molecular analyses of various 
brain regions would be possible and provide insight into mechanisms of disorder. 
Scientists have demonstrated that chronic consumption of excess fat induces cognitive 
impairment in rodents within 1 week (Beilharz, Maniam, & Morris, 2016). This high-fat feeding 
impairment appears to persist during longer (e.g., 8 months) dietary interventions (Stranahan et 
al., 2008). Although the literature indicates high-fat consumption leads to cognitive impairment, 
different dietary parameters, as well as animals used, preclude establishment of a timeframe of 
cognitive decline. A study by Gainey et al. (2016) compared 6-week-old C57BL/6J (6J) mice, 
using a control group with a low-fat diet (10% fat), and an experimental group consuming a high-
fat diet (60%), and investigated cognitive and anxiety symptoms. They tested cognitive and 
behavioral dysfunction with separate groups at 1 week, 3 weeks, or 6 weeks of consumption 
history, with each time point having a low-fat control and a high-fat diet group. They found that 
after 1 week of high-fat consumption, mice had impaired memory as assessed with the Novel 
Object Recognition (NOR) test. The 3-week consumption history high-fat diet group performed 
worse in the object learning recognition tasks and the 6-week group showed increased anxiety 
symptoms in the Open Field Test (OF) and Elevated Zero Maze Task (EZM). This indicates that 
consumption history differentially affects the outcome of specific tasks, and cognitive and 
behavioral symptoms vary across consumption history. Understanding a timeframe for the 
development of high-fat diet-induced memory impairment will help advance understanding of the 
development of early cognitive impairment.  
Dietary animal studies have given us insight into specific brain regions that are more 
vulnerable to high-fat feeding. These regions include the hippocampus, frontal cortex and thalamus 
(Cordner & Tamashiro, 2015; Greenwood & Winocur, 2005; Kaplan & Greenwood, 1998; Pistell 
et al., 2010; Stranahan et al., 2008; Winocur & Greenwood, 2005). Hippocampal-dependent tasks, 
which are important for spatial learning and memory, were the most vulnerable to a high-fat diet 
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(Granholm et al., 2008; Winocur & Greenwood, 2005; Stranahan et al., 2008). The most common 
hippocampal-dependent tasks include the Morris Water Maze (MWM), Barnes Maze, Radial Arm 
Maze (RAM), T and Y maze, and NOR; rodents given a high-fat diet in these tasks typically 
showed poorer performance (Cordner & Tamashiro, 2015). Reversal learning in the MWM and 
Barnes Maze are considered prefrontal cortex- and striatum-dependent, which is also affected by 
a high-fat diet (Cordner & Tamasiro, 2015). Other deficits such as procedural learning, short-and 
long-term memory, and general intellectual functioning show poorer performance as a 
consequence of high-fat consumption (Greenwood & Winocur, 2005; Kaplan & Greenwood, 1998; 
Pistell et al., 2010; Stranahan et al., 2008; Winocur & Greenwood, 2005). The MWM and RAM 
are the most common behavioral task used to assess cognitive impairment due to a high-fat diet. 
The MWM & RAM was found to be hippocampal dependent, more specifically by NMDA 
receptors. Cordner & Tamashiro (2015) found that several studies gave NMDA antagonist to 
rodents and performance on the MWM or the RAM was impaired. The Barnes maze, T and Y-
Maze, and NOR tasks are other hippocampal dependent task that has shown impairment due to a 
high-fat diet, except they are not dependent on NMDA receptors. Lesion studies have given insight 
into brain regions involved in these behavioral tasks: Lesions of the hippocampus has found to 
impact the MWM, RAM, and Barnes Maze. Furthermore, modifications to the MWM, RAM, and 
Barnes Maze to measure reversal learning have shown deficits when there are lesions in the 
prefrontal cortex and striatum. 
Lesion studies and transgenic mice have shown that the T-Maze is dependent on the 
hippocampus, septum, prefrontal cortex, basal forebrain, thalamus, striatum and cerebellum 
(Cordner & Tamashiro, 2015). Lesion on the NOR task show that the hippocampus is important 
for recall of an object’s place otherwise known as Object Recency, whereas lesions to the 
prefrontal cortex and perineal cortex is involved in novel object preference. Arnold et al. (2014) 
found that a high-fat diet is associated with abnormal neuroanatomic integrity of hippocampal CA3 
dendrites and spines, evidence was shown more with impaired working memory using the T-maze. 
Furthermore, cortical and hippocampal regions showed the development of insulin resistance 
demonstrating insulin signaling is disrupted. All in all, high-fat consumption has been reported to 
impair these specific behavioral tasks, which are brain region dependent. Therefore, it shows 
evidence for specific brain regions are more vulnerable to high-fat consumption.  
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A majority of high-fat diet studies are conducted in rats, with limited number utilizing mice 
in recent years. Characterization of high-fat diet effects in mice would seem important given the 
vast potential of mutant mouse models to help inform the mechanisms by which high-fat diet leads 
to behavioral impairment. 6J mice were first utilized in high-fat feeding in 1988 (Surwit et al., 
1988). According to Alexander, Chang, Dourmashkin & Leibowitz (2006), the target goal is to 
have an animal model that reflect physiological changes similar what is seen in humans. Inbred 
strains such as the 6J mice are helpful since they can be genetically specific and modified to reflect 
human pathology (Alexander, Chang, Dourmashkin & Leibowitz, 2006; King, 2012). 6J mice were 
found to be susceptible to the high-fat effects, which have led to the development of obesity, 
hyperinsulinemia and altered glucose homeostasis (Alexander, Chang, Dourmashkin & Leibowitz, 
2006; Winzell & Ahren, 2004). Also, mice have a shorter generation time, which allows 
longitudinal studies to be more efficient (King, 2012).   
While high-fat feeding studies with mice provide an essential experimental tool to 
understand etiological aspects of obesity-related disease, a large majority of these feeding studies 
utilize a diet that provides ~60% of total calories from fat (Arnold et al., 2015; Gainey et al., 2016; 
Kleine et al., 2016), which exceeds Western Society’s upper limits estimated to be at 45% of total 
calories from saturated fats (Stranahan et al., 2008). Furthermore, Pistell et al. (2010), using the 
Stone T-Maze spatial learning and memory task with high-fat fed (40% and 60% kcal from 
saturated fat) 6J mice, found impairment with consumption of the 60%, but not at 40% of a high-
fat diet. Notwithstanding, however, many aspects of that study (e.g., mouse strain, diet duration, 
etc.) could explain the lack of an effect of a diet that is closely akin to that eaten in Western society 
on metabolic and brain health. 
1.4 High-Fat Diet & Emotional Dysregulation 
There are a limited number of studies investigating the relationship between high-fat diet 
and behavioral dysregulation such as anxiety and depression. A recent study by Gainey et al. 
(2016) investigated both cognitive and anxiety-like behavior in independent groups of 6J mice at 
1, 3, or 6 weeks of high-fat diet consumption. Anxiety-like behavior was exhibited at the 6-week 
timeframe using the OF and EZM task. Similarly, Sharma and Fulton (2013) found that 12 weeks 
of a high-fat diet (58%) induced anxiety and depressive like behavior in obese 6J mice using the 
EPM, OF, & FS test. A gap in the literature exists in assessing anxiety and depressive symptoms 
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reflective of high-fat consumption of a Western diet. Some studies show that palatable foods (i.e., 
high-fat foods) alleviate depression and anxiety symptoms for a short period, further reinforcing 
consumption during stressful events (Maniam & Morris, 2010; Maniam, Antoniadis, Le & Morris, 
2016). Sharma et al. (2013) used 6J mice and placed them on a 6-week high-fat diet (58% fat); 
they exhibited signs of anhedonia, anxiety, and sensitivity to stressors during withdrawal. These 
studies provide evidence that a high-fat diet can influence behavioral dysregulation. As presented 
later, studies currently underway support the hypothesis that chronic consumption of a high-fat 
diet (45%) reflective of a Western diet may exhibit anxiety and depressive symptoms. 
1.5 High-Fat Diet & Insulin Resistance 
Studies suggest that chronic consumption of a high-fat diet leads to cognitive impairment 
through the promotion of insulin resistance (Greenwood & Winocur, 2005; Stranahan et al., 2008; 
Winocur & Greenwood, 2005). Winocur & Greenwood (2005) compared Zucker fa/fa rats that are 
insulin resistant with rats fed a high-fat diet for 3 months and found similar impairments on the 
cognitive tasks compared to their respective controls. They theorized that high-fat induced 
cognitive impairment may be due to insulin resistance and decreased glucose uptake in the brain. 
So they did another study with the same design and they found baseline scores showing 
impairment, but the next day half the group was given an intraperitoneal injection of glucose (100 
mg/kg BW) or saline (equal amounts) and found improvement in the glucose treatment group 
(Winocur & Greenwood, 2005). In an earlier study, Greenwood and Winocur (1996) found that 
saturated fatty acid was a major contributor to cognitive impairment when rats were fed a diet of 
saturated fats, monounsaturated fats, or polyunsaturated fats. Evidence suggests that high-fat 
consumption at 45% in mice and humans are equivalent since they have similar physiological 
changes during the development of insulin resistance (Arnold et al., 2015; Bhonagiri et al., 201l; 
Fisher-Wellman, et al., 2016; Habegger et al., 2012; Penque, Hoggatt, Herring, & Elmendorf 
2013). A study by Lee et al. (2011) showed high-fat diet induces insulin resistance as early as 3 
days. These studies indicate a relationship between a high-fat diet and insulin resistance and 
suggest that insulin resistance or a similar etiological factor for both insulin resistance and brain 
dysfunction cause cognitive decline. 
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1.6 High-fat Diet: Cholesterol-Insulin Resistance Interaction in Periphery 
Chronic consumption of a high-fat diet has been implicated in contributing to abnormal 
cholesterol metabolism, which has been linked to insulin resistance and impaired cognition 
(Suzuki et al., 2010). The blood-brain barrier is known to regulate cholesterol influx from the 
circulation, and the cellular cholesterol demand of the brain depends on the regulation of 
underlying cholesterol biosynthesis in the peripheral nervous system (Bjorkhem & Meaney, 2004; 
Dietschy & Turley, 2004). A high-fat diet induces a response in the adipose tissue and skeletal 
muscle that increases plasma membrane (PM) cholesterol content (Habegger et al., 2012, Ambery 
et al., 2017). These and other studies found that the excess membrane cholesterol causes insulin 
resistance in these tissues by reducing cortical actin filaments that are essential for the insulin-
stimulated glucose transporter (GLUT4)-mediated glucose transport (Bhonagiri et al., 201l; 
Habegger et al., 2012a; Penque, Hoggatt, Herring, & Elmendorf 2013). Human skeletal muscle 
data also show that insulin-stimulated glucose disposal is inversely related to membrane 
cholesterol content (Habegger et al., 2012). Strikingly, lowering the excess membrane cholesterol 
to levels seen in insulin-sensitive skeletal muscle fully restores insulin sensitivity (Bhonagiri et al., 
201l; Habegger et al., 2012a; Habegger et al 2012b).  
Mechanistically, in vitro data suggest that membrane cholesterol accumulation results from 
increased glucose flux through the hexosamine biosynthesis pathway (HBP) (Bhonagiri et al., 
201l; Habegger et al., 2012a; Penque, Hoggatt, Herring, & Elmendorf 2013), a pathway well-
recognized to cause insulin resistance and play a key role in the etiology of T2D (Buse, 2006; 
McClain & Crook, 1996). Marshal, Bacote, & Traxinger (1991) first demonstrated that HBP 
activity was involved in the development of insulin resistance in adipose tissue and skeletal muscle 
(Fig. 1). Glucose entry into the HBP is catalyzed by the first and rate-limiting enzyme: GFAT, 
which converts fructose-6-phosphate and glutamine into glucosamine-6-phosphate (GlcN-6-P). 
GlcN-6- P is subsequently metabolized, culminating in the production of UDP-N-
acetylglucosamine (UDP-GlcNAc), the high-energy substrate for O-GlcNAc transferase (OGT), a 
nuclear and cytosolic enzyme that catalyzes the addition of GlcNAc to serine/threonine residues 
(Kreppal, Blomberg, & Hart, 1997; Lubas, Frank, Krause, & Hanover, 1997). This 
posttranscriptional modification modulates the activities of signaling proteins, regulates most 
components of the transcription machinery, effects cell cycle progression and regulates the 
targeting/turnover or functions of many other regulatory proteins (Hart, 2014). In transgenic mice, 
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overexpression of OGT and GFAT lead to insulin resistance (Cooksey et al., 1999; Herbert et al., 
1996; McClain et al., 2002).  
In vitro study suggests that increased HBP activity is responsible for the increase 
cholesterol accumulation by increasing the O-linked N-acetylglucosamine modification of the 
transcription factor Sp1, leading to transcriptional activation of HMG-CoA reductase (HMGR), 
the rate-limiting enzyme in cholesterol biosynthesis (Fig. 2) (Bhonagiri et al., 201l; Habegger et 
al., 2012; Penque, et al, 2013). Blocking HBP or Sp1 from attaching to DNA has been shown to 
reduce cholesterol accumulation and GLUT4/glucose transport dysregulation in cultured cells 
(Bhonagiri et al., 201l; Habegger et al., 2012; Penque, et al., 2013). 
1.7 High-Fat Diet: Central Nervous System 
Brain cholesterol is primarily made in situ within the brain (Granholm et al., 2008; Ferris 
et al., 2017; Suzuki et al., 2010). However, evidence suggests that elevations in cholesterol, insulin 
and glucose in the peripheral nervous system may influence brain cholesterol synthesis within the 
brain, and that this may in turn be linked to Alzheimer’s-like neurobiological changes. Diabetes 
research has shown evidence that during pre-diabetic stages, there is an elevation of brain 
cholesterol, whereas, there is a depletion of brain cholesterol when an individual is diabetic (Ferris 
et al., 2017; Ismail et al., 2017; Refolo et al., 2000; Suzuki et al., 2010).  
A study by Refolo et al. (2000) investigated the link between cholesterol metabolism and 
AD. They wanted to test if increased cholesterol had an effect on amyloid accumulation using 
hemizygous, double-mutant PSAPP transgenic mice (Crossbreed between APPK670N, M671L, and 
PS1M146V), which contain the familial human risk genes APP and PSI. They fed the transgenic 
mice a high-fat diet for 7 weeks and showed cholesterol was elevated in both the peripheral and 
central nervous system. Elevated cholesterol was shown to increase amyloid accumulation by 3 
measures: sandwich ELISA, IP/MS, and immunohistochemical/image analysis of serial sections. 
This supports our model that increased HBP activity occurring in fat/muscle causes peripheral 
insulin resistance and that this may be occurring at the same time increased HBP activity in the 
brain is contributing to cognitive decline.  
The prevailing hypothesis has been that elevated brain cholesterol comes about by the 
movement of peripheral cholesterol across the blood-brain barrier after its synthesis in the 
periphery. There is a gap in the literature with respect to how cholesterol becomes elevated in the 
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brain; indeed, even though the prevailing view is that peripheral cholesterol can get into the brain, 
the blood-brain barrier is not thought to allow cholesterol to get across. According to Suzuki et al. 
(2010), it is theorized that insulin in the peripheral nervous system increases and is able to cross 
the blood brain barrier via a receptor-mediated transport. So as insulin increases in the peripheral 
nervous system, it will travel to the brain and influence insulin signaling that will increase de novo 
brain cholesterol biosynthesis. Another theory to explain the elevated brain cholesterol is by Ferris 
et al. (2017), who hypothesized that there is an alteration in the astrocytes with affected SREBP2 
mediated cholesterol synthesis. Lastly, although the blood brain barrier blocks cholesterol in the 
peripheral nervous system, there is an active cholesterol metabolite named 27 Hydroxycholesterol 
(27-OH), and it is thought to cross the blood brain barrier. Excess 27-OH will increase brain 
cholesterol and reduce brain glucose uptake (GLUT4 expression impaired) (Ismail et al., 2017). 
Preliminary data we have supports the hypothesis that elevated brain cholesterol comes about by 
de novo HBP-mediated synthesis of cholesterol in the brain as a consequence of high-fat diet 
consumption. 
In conclusions, there is a lack of an established timeframe of the progression of cognitive 
and behavioral dysfunction. Behavioral dysregulation, such as anxiety and depression symptoms 
during chronic consumption of a high-fat diet, is limited. Characterization of high-fat diet effects 
in mice are important given the vast potential of mutant mouse models to help inform the 
mechanism(s) by which high-fat diet leads to cognitive and behavioral impairment. Also, an 
established correlation between cognitive, behavioral, and physiological changes can help develop 
a better picture of these relationships. All in all, specific aims presented next were designed to fill 
in significant gaps in the literature by developing a longitudinal study to assess the progression of 
cognitive and behavioral dysfunction and associated brain cholesterol, and to delineate 
mechanisms of brain cholesterol buildup. 
1.8 Specific Aims 
1. Determine if consumption of a high-fat diet leads to cognitive impairment and behavioral 
dysfunction at 3, 8, or 13 weeks of consumption. I hypothesized that increased consumption 
duration will increase cognitive and behavioral impairment. 
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2. Determine if cholesterol levels and HBP activity are aberrantly increased in specific brain 
regions in mice that display feeding-induced cognitive/behavioral dysfunction. I hypothesized that 
vulnerable brain regions will have elevated cholesterol levels as a result of aberrantly increased 
HBP activity. 
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CHAPTER 2 METHODS & MATERIALS 
2.1 Aim 1 General Design 
A longitudinal experimental design was used to study time-related changes in cognitive 
performance and affect behavior. 5-week old male C57BL/6NJ (6N) mice obtained from Jackson 
Laboratory were used in this study. The mice were randomly assigned to one of two groups: either 
a low-fat or high-fat group. Following a 1 week acclimation period on the low-fat diet, to acclimate 
to the taste of palm oil and prevent any positive or negative contrast that may occur to switching 
feed, the mice were 6 weeks old and either switched to a high-fat diet or were continued on the 
low-fat diet. 
Separate groups of 6N mice were tested at 3-, 8-, or 13 weeks of high-fat or low-fat diet 
consumption. Preliminary data indicated that these time points were able to assess the progression 
of cognitive impairment, and there were differences in performance between feeding conditions in 
the MWM (not graphed). I hypothesize that chronic consumption of the high-fat diet will increase 
anxiety-like behavior in the EPM and OF tests, increase depression-like-behavior in the forced 
swim (FS) test, and impair cognitive performance in the MWM. I anticipate that some or all of 
these effects might emerge as a function of time on the high-fat diet, which makes the longitudinal 
design an important aspect of the experiment. 
2.2 Mouse Model 
6N mice express nicotinamide nucleotide transhydrogenase (NNT, an enzyme that protects 
against reactive oxygen damage known to harm pancreatic insulin secretory processes) that is not 
expressed in the widely used 6J substrain. 6N mice have been shown to display insulin secretion 
and fasting hyperinsulinemia under high-fat feeding conditions similar to the human condition 
(Fisher-Wellman, et al., 2016). Use of the 6N mice affords a more precise model of insulin 
resistance in humans during high-fat feeding (Fisher-Wellman, et al., 2016). A total of 60 mice 
were used [10 mice per subgroup x 3 subgroups (3, 8 or 13 weeks) x 2 diets (LF and HF) = 60]. 
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2.3 Specialty Food 
The low-fat diet contains 20% kcal from protein, 70% kcal from carbohydrates, and 10% 
kcal from fat (DO1030107, Research Diets, Inc.). This low-fat, as well as the high-fat, diet 
represented modified forms of the standard low-fat (D12450B) and high-fat (D12451) diets from 
this supplier, with adaptations regarding type of fat (palm oil instead of lard) and carbohydrates, 
to better mimic the fatty acid/carbohydrates of the average diet in Western societies. At 6 weeks 
of age, the group designated for a high-fat diet were switched to the HF feed containing 20% kcal 
from protein, 35% kcal from carbohydrates, and 45% kcal from fat (D01030108) for 8 weeks. This 
diet mimics the percent of saturated to monounsaturated to polyunsaturated fatty acids (40:40:20). 
The group designated for the low-fat diet continued on this diet for the designated timeframe. 
2.4 Body Weight Measurement 
The body weight of all mice was measured during the first and last week of testing with an 
Ohaus CS200-001 Portable Compact Scale. Body weight of each mouse was measures in grams. 
This allowed us to measure any weight difference due to aging and high-fat diet consumption.  
2.5 Behavioral Assessment 
2.5.1 Elevated Plus Maze 
The EPM is an assessment of anxiety-like behavior in rodents (Walf & Frye, 2007). The 
apparatus is configured in a plus shape (+) and comprised of two open arms (34.6 cm x 7.3 cm) 
and closed arms (34.6 cm X 7.3 cm) elevated 74.3 cm from the ground. Room lighting consisted 
of a mix of red light with ambient light near the apparatus to allow the open arms to be 40 lux and 
the closed arms 12 lux. This maze assesses anxiety-like behavior due to the mouse’s natural 
response to avoid open areas and find closed areas. Therefore, recording the number of open arm 
entries and the amount of time spent in the open arms has been validated as a measure of anxiety 
in the mice (Walf & Frye, 2007). Drugs that are anxiogenic reduce the amount of time in open 
arms, whereas anxiolytic drugs increase the time spent in open arms. The mice were placed in the 
center of the maze and their behavior recorded for 5 minutes, and the amount of time spent and 
entries into the open arms were recorded using a video camera, and manually scored. 
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2.5.2 Open Field Test 
The OF measures general locomotor activity and anxiety-like behavior in rodents. The 
mice were placed in a Plexiglas box (40 cm x 40 cm x 30 cm) that contains photocell beams along 
the perimeter to detect the location of the rodent vertically and horizontally and the distance 
traveled is measured. The chamber is an enclosed apparatus that is lit by a light and is ventilated 
with a fan in the back wall. The mice were placed in the center of the chamber and recorded for 
30 minutes. Assessment for total distance and amount of time in the center of the box compared 
to peripheral areas is measured. It is natural for rodents to spend time on the outer edges if they 
are anxious, called thigmotaxis. Thigmotactic behavior is recorded if they were in the center of the 
locomotor box with a length 20 cm x width 20 cm. When mice spend time in the center location, 
it is a sign they are less anxious. Certain drugs such as benzodiazepines have an anxiolytic effect 
in mice and the center time is increased. 
2.5.3 Morris Water Maze 
The MWM is a behavioral task to assess spatial learning and memory. The pool is 125cm 
in diameter and a circumference of 785.4 cm. The pool was filled to within 25 cm of the rim of the 
tank. The temperature of the pool was 24- 26 °C water which was made cloudy by adding non-
toxic white paint. This experiment assesses spatial learning and memory in the first phase, 
reference memory in the second phase, and visual acuity or weight difference in the third phase.   
The first phase of MWM experiment was the hidden platform task and assessed spatial 
navigation, and the rodent's ability to quickly find the platform. The mice rely on cues in its 
environment to remember where the platform is located. The mice were placed in the water (24-
26oC) and swam to a submerged platform (Hidden) within 60s. The location to drop the mouse 
into the pool was randomly chosen and not in the same quadrant as the hidden platform or the 
platform's adjacent sides. The mice were tested in four trials per day, at 60s each, over 7 days. The 
hidden platform did not move from its location across trials or days. Furthermore, software 
technology (HVS image, Hampton, UK) recorded the movement of the mice in order to determine 
path lengths thigmotaxis, speed and floating.  
On day 7, after the last hidden platform trial, the mice completed a probe trial that assessed 
reference memory to see if the mice have learned the location of the platform. The platform was 
15 
 
removed, and the mice were placed into the pool and monitored for swim search behavior 
measured as preference for target location along with measured of path length, thigmotaxis, 
floating and swim speed.  The stronger the tendency for the mouse to swim in the area where the 
platform was previously hidden. The stronger the spatial bias acquisition in the hidden platform 
training. 
Lastly, the mice were tested in a visible platform trial. useful for assessing any general 
performance deficits including any visual impairment, effects of weight difference, motivational 
differences or other possible deficits due to high-fat consumption other than spatial cognition. This 
test consists of the platform being placed above the water line, and black tape is used on the edges 
of the platform to make it visible to the mouse swimming in the tank. The visual platform was 
randomly placed in a different quadrant at each trial, and the mice were placed in the pool in a 
location that was not in the same quadrant as visible platform. Measurements such as latencies, 
path lengths, thigmotaxis, floating and speed were recorded for each trial. 
2.5.4 Forced Swim Test 
The FS test is utilized to assess depression-like behavior. The mice were placed in a 2000 
ml beaker (Height 19.3cm & Diameter 13.1cm) with water (24-26C) filled to 1400 ml that is 
inescapable for 6 minutes and scored for immobility. Mice showing depressive-like behavior 
expressed a higher amount of time spent being immobile. The amount of time spent immobile was 
recorded for the last 4 minutes of the 6-minute test; data show that in the initial two minutes of the 
task, mice are very active and react to placement into an inescapable apparatus. This task is 
considered not fully reflective of human depression, however, there is considerable predictive 
validity when assessing antidepressant medication used to treat depression in humans. 
Antidepressants have been shown to reduce immobility time in rodents; this gives credibility for 
assessment of depressive symptoms. 
2.6 Aim 2 Cholesterol Analysis 
After the behavioral assessments, brains of all mice were extracted, and the cerebral 
cortices, hippocampi, and cerebella were isolated, frozen in 2-methylbutane, and stored in 
microcentrifuge tubes (Fisherbrand). These isolated brain regions were delivered to the Elmendorf 
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lab for cholesterol content and HBP activity measures. Differences between the low-fat and high-
fat groups and between the 3, 8, and 13 week groups will be determined.  
Briefly, lysates of the isolated brain regions will be prepared via polytron homogenization 
in a detergent-free HES buffer [20 mM HEPES (pH 7.4), 1 mM EDTA, and 255 mM sucrose 
containing 1 mM phenylmethylsulfonyl fluoride, 10 μg/ml pepstatin, 10 μg/ml aprotinin, and 5 
μg/ml leupeptin]. The detergent-free lysate is used to measure cholesterol using the Amplex Red 
Cholesterol Assay Kit as routinely performed (Penque et al., 2013). To accurately determine the 
total protein content of the detergent-free HES lysate, a well-mixed sample of the lysate will be 
mixed with NP40 detergent and the protein amount in the solubilized lysate will be determined 
with the Bradford protein assay. Cholesterol content in each sample will be normalized to the total 
protein amount in each sample. The solubilized lysates will also be used to measure mRNA/protein 
(e.g. HMGR) expression, as well as O-GlcNAc modification of Sp1 as routinely performed in the 
lab to assess the HBP-mediated cholesterolgenic response [Bhonagiri et al., 2011; Habegger et al., 
2012; Penque et al., 2013]. 
2.7 Statistical Analysis 
2.7.1 Body weight 
An unpaired t-test was used to compare body weight differences between the low-fat diet 
and high-fat diet group during behavioral testing at each consumption history time point (3, 8. & 
13 weeks). 
A Pearson correlation coefficient was calculated to assess a relationship between specific 
consumption history groups’ body weight and behavioral tasks in the Elevated Plus Maze (Total 
entries, open and closed entries, and open and closed times), Open Field Test (Total distance, 
center distance, and center time), Morris Water Maze (Latencies, path lengths, speed, thigmotactic 
behavior and floating) and Forced Swim Test (Immobility). Significance was determined at 
p<0.05. 
2.7.2 Elevated Plus Maze 
An unpaired t-test was used to compare the open arm and closed arm; more specifically, 
entries and time in the open and closed arms was analyzed in the high-fat diet group and low-fat 
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diet (control) group. A one-way ANOVA was used to compare across consumption history groups. 
Where a significant difference was measured, a Sidak’s multiple comparisons test was used to 
compare individual groups. Significance was determined at p<0.05 in all measurements. 
2.7.3 Locomotor/Open Field Test 
For the Locomotor/Open Field Test the mean ±SEM of general locomotor activity and time 
spent in the center were compared using an unpaired t-test between the high-fat diet group 
(treatment) and low-fat diet (control) group. A two-way ANOVA was used to compare across 
consumption history groups and feeding conditions. Significance was determined at p<0.05 in all 
measurements. 
2.7.4 Morris Water Maze 
For each duration of feeding, a two-way mixed ANOVA with diets as a grouping factor 
and training as a repeated measure was used to compare mean daily latencies, path lengths, 
thigmotaxis, floating and speed during the acquisition and also for the visible platform training. 
During the probe trial, a two-way mixed ANOVA with diet as a grouping factor and quadrant as a 
within-subjects factor was used to assess preference for the location by measuring time in seconds. 
An independent groups t-test was used to compare differences in Probe Trial thigmotactic behavior 
(time and path), speed and floating. Significance was determined at p<0.05 in all measurements. 
2.7.5 Forced Swim Test 
Time spent immobile in the high-fat diet (treatment) group and low-fat (control) group was 
compared using an unpaired t-test. One-way ANOVA was used to compare across consumption 
histories for each feeding condition. Significance was determined at p<0.05 in all measurements. 
2.7.6 Cholesterol Analysis 
A two-way ANOVA will be used to find a main effect difference between feeding 
conditions and consumption history group of cholesterol levels at each specific brain region 
(hippocampus, cerebral cortices & cerebellum). Significance will be determined at p<0.05. An 
unpaired t-test will be used to measure individual groups and brain regions. 
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CHAPTER 3 RESULTS 
3.1 Elevated Plus Maze: Anxiety Measures 
3.1.1 Week 3 
An independent groups t-test was conducted to compare open and closed arm entries and 
time between the low-fat and high-fat diet group in order to assess differences in anxiety behavior. 
It was predicted that the high-fat diet group would have less entries and time in the open arm and 
increased entries and time in the closed arms. In the week 3 group, there was not a significant 
difference in open or closed arm entries between the low-fat and high-fat groups [t(18) = 0.8155, 
p =.4255, for open arm entries; t(18) = 0.6821, p =.5039, for closed arm entries], (Fig. 3A, Fig. 
3B). There was not a significant difference in time spent in the open arm and closed arm between 
the low-fat and high-fat groups [t(18) = 0.2514, p =.8043, for open arm time; t(18) = 0.1344, p 
=.8946], (Fig. 3C, Fig. 3D). The high-fat diet group did not show higher anxiety behavior as 
indicated by similar entries and time into the open and closed arm compared to the low-fat diet. 
3.1.2 Week 8 
An independent groups t-test was conducted to compare open and closed arm entries and 
time between the low-fat and high-fat diet group in order to assess differences in anxiety behavior. 
It was predicted that the high-fat diet group would have less entries, and time in the open arm and 
increased entries and time in the closed arms. In the week 8 group, there was not a significant 
difference in open or closed arm entries between the low-fat and high-fat groups [t(18) = 1.789, p 
=.0905, for open arm entries; t(18) = 0.1089, p =.1552, for closed arm entries], (Fig. 4A, Fig. 4B). 
There were no significant differences in time spent in the open arm and closed arm between the 
low-fat and high-fat groups [t(18) = 1.621, p = .1224, for open arm time; t (18) =1.4, p = .1784], 
(Fig. 4C, Fig. 4D). The high-fat diet group failed to show higher anxiety behavior as indicated by 
similar entries and time into the open and closed arm compared to the low-fat diet. 
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3.1.3 Week 13 
An independent groups t-test was conducted to compare open and closed arm entries and 
time between the low-fat and high-fat diet group in order to assess difference in anxiety behavior. 
It was predicted that the high-fat diet group would have less entries and time in the open arm, and 
increased entries and time in the closed arms. In the week 13 group, on average, there was not a 
significant difference in open or closed arm entries between the low-fat and high-fat groups [t(18) 
= 1.24, p = .2309, for open arm entries; t(18) = 0.94, p = .3597, for closed arm entries], (Fig. 5A, 
Fig. 5B). There were no significant differences in time spent in the open arm and closed arm 
between the low-fat and high-fat groups [t(18) = 0.8671, p = .3973, for open arm time; t(18) = 
1.501, p = .1507], (Fig. 5C, Fig. 5D). The high-fat diet group failed to show higher anxiety-like 
behavior as indicated by similar entries and time into the open and closed arm compared to the 
low-fat diet. 
3.1.4 Across-group comparison 
An independent groups t-test was conducted to compare open arm entries and time between 
consumption history groups in order to assess differences in anxiety behavior. It was predicted that 
increased consumption duration would have less entries and time in the open arm due to increased 
anxiety behavior. Consumption duration had a significant effect on the number of entries in the 
low-fat group [main effect of consumption history, F(2, 27) = 8.184, p = .0017]. Using the Sidak’s 
multiple comparisons test to analyze individual groups, the 3 week group had a higher number of 
entries compared to the 8week group t (27) = 3.72, p = .0028 and 13 week group t(27) = 3.238, p 
= .0095 (Fig. 6A). In contrast, when analyzing the low-fat diet group on time spent in open arms, 
there was not a significant difference between consumption duration (Fig. 6B). The low-fat diet 
group at 3 weeks displayed less anxiety-like behavior as indicated by the higher number of entries 
compared to the 8week and 13week group. 
An independent groups t-test was conducted to compare open and closed arm entries 
between consumption history groups in order to assess differences in anxiety behavior. It was 
predicted that increased consumption duration would have less entries and time in the open arm. 
Consumption durations had a significant effect on the number of entries in the high-fat diet group 
[main effect by consumption history, F(2, 27) = 10.83, p = .0004]. The 3week group had a higher 
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number of entries compared to the 8week group t(27) =4.279, p=.0006 and the 13week group t(27) 
= 3.724, p = .0027 (Fig. 6C). Similarly, consumption duration had a significant effect on the time 
spent in the open arms in the high-fat diet group [main effect by consumption duration, F(2, 27) = 
5.268, p = .0117]. Using the Sidak's multiple comparisons test to analyze individual groups, the 
3week group had a higher time spent in the open arms compared to the 8week group t(27) = 3.148, 
p = .0119 (Fig. 6D). The high-fat diet group at 3 weeks displayed less anxiety-like behavior as 
indicated by the higher number of entries and time compared to the 8week and 13week group. 
3.2 Locomotor Data (Open Field Test): Anxiety & General Activity 
3.2.1 Week 3 
An unpaired t-test was conducted to assess general locomotor activity (total distance) and 
anxiety behavior (center distance and time) between the low-fat diet group and the high-fat diet 
group. It was hypothesized that the high-fat diet group will display less general locomotor activity 
and increased anxiety behavior. There was no significant difference between the low-fat and high-
fat diet groups in total distance, center distance, and percentage distance traveled in the center (Fig. 
7A, Fig. 7B, Fig. 7C). There was not a significant difference in time spent in the center or 
percentage of time in the center between the low-fat diet group and the high-fat diet group (Fig. 
7D, Fig. 7E). This indicates that the feeding conditions did not differ in general locomotor activity 
or anxiety behavior in the OF test. 
3.2.2 Week 8 
An unpaired t-test was conducted to assess general locomotor activity (total distance) and 
anxiety behavior (center distance and time) between the low-fat diet group and the high-fat diet 
group. It was hypothesized that the high-fat diet group will display less general locomotor activity 
and increased anxiety behavior. On average, the low-fat diet group traveled more compared to the 
high-fat diet group t(18) = 2.651, p = .0162 (Fig. 8A). The low-fat diet group and high-fat diet 
group did not have a significant difference between in the distance traveled in the center or the 
percentage of distance in the center (Fig. 8B, Fig. 8C). There was not a significant difference in 
time spent in the center or percentage of time spent in the center between the low-fat diet group 
and the high-fat diet group (Fig. 8D. Fig. 8E). This indicates that the high-fat diet group had a 
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lower general locomotor activity compared to the low-fat diet group. There was no difference in 
anxiety-like behavior between feeding conditions as indicated by center distance and time. 
3.2.3 Week 13 
An unpaired t-test was conducted to assess general locomotor activity and anxiety behavior 
between the low-fat diet group and the high-fat diet group. It was hypothesized that the high-fat 
diet group will display less general locomotor activity and increased anxiety behavior. On average, 
the low-fat diet group traveled more compared to the high-fat diet group t(18) = 2.829, p = 
.0111(Fig. 9A). The low-fat diet group traveled more in the center of the locomotor box compared 
to high-fat diet group t(18) = 2.829, p = .0111 (Fig. 9B). The low-fat diet group spent a greater 
percentage of time in the center compared to high-fat diet group t(18) = 2.809, p = .0116 (Fig. 9C). 
 On average, the low-fat diet group spent a higher amount of time in the center compared 
to high-fat diet group t(18) = 2.584, p = .0187 (Fig. 9D). Analyzing the percentage of time spent 
in the center, the low-fat diet group spent a higher percentage of time in the center compared to 
the high-fat diet group t(18) = 2.584, p = .0187 (Fig. 9E). The high-fat diet group had less general 
locomotor activity as indicated by less total distance. The high-fat diet group showed anxiety 
behavior has indicated by less distance and time traveled in the center of the locomotor box.  This 
confirmed our hypothesis that the high-fat diet group would have less general locomotor activity 
and increases anxiety behavior. 
3.2.4 Across-group comparison 
A two-way ANOVA was conducted to analyze general locomotor activity between feeding 
conditions and consumption histories. When analyzing total distance, there was a significant main 
effect on consumption history [main effect by consumption history, F(2, 54) = 183, p<.0001]. 
There was a significant main effect on feeding condition [main effect by feeding condition, F(1, 
54) = 16.51, p = .0002] (Fig. 10A). There were significant differences in general locomotor activity 
as indicated by total distance between feeding conditions and consumption history groups.  
A two-way ANOVA was conducted to analyze general locomotor activity between feeding 
conditions and consumption histories. When analyzing center distance, there was a significant 
main effect on consumption history [main effect by consumption history, F(2, 54) = 20.89, 
p<.0001]. There was a significant main effect on feeding condition [main effect by feeding 
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condition, F(1, 54) = 7.728, p = .0075] (Fig. 10B). There were significant differences in anxiety-
like behavior as indicated by center distance between feeding conditions and consumption history 
groups. 
A two-way ANOVA was conducted to analyze general locomotor activity between feeding 
conditions and consumption histories. When analyzing center time, there was a significant main 
effect on consumption history [main effect by consumption history, F(2, 54) = 183, p = .0006]. 
There was a significant main effect on feeding condition [main effect by feeding condition, F(1, 
54) = 16.51, p = .0399] (Fig. 10C). There were significant differences in anxiety-like behavior as 
indicated by center time between feeding conditions and consumption history groups. 
3.3 Morris Water Maze: Cognition 
3.3.1 MWM Task (Week 3) 
Measure of latencies and path lengths to reach the platform during all phases of the MWM 
assessed cognitive behavior. Performance was assessed by measuring swim speed, thigmotaxis 
and floating. Each cognitive and performance measure was analyzed using a two-way group x day 
repeated measures ANOVA during the hidden and visible platform phase. During hidden platform 
acquisition, both diet groups showed significant reduction in latencies and path lengths over days 
[main effect of day, F(6, 234) = 10.57, p<.0001, for latencies; F(6, 54) = 21.3, p<0.0001 for path 
lengths]. However, there were no significant main or interactive effects of diet (Fig. 11A, Fig. 
11B). Furthermore, both groups showed there was a reduction in thigmotaxis behavior [main effect 
of day F(6, 54) = 4.443, p = .0010]. There was no significant difference in swimming speed over 
days or between diet groups (Fig. 11C). There was no significant main effect or interactive effects 
on diet on thigmotaxis and floating (Fig. 11D, Fig. 11E). In summary, both feeding groups showed 
acquisition to the hidden platform across days, but no difference between feeding conditions. There 
was also increased thigmotactic behavior, which can affect cognitive behavior, and interpretation 
of cognitive behavior may be uninterruptable. 
During the visible platform test, both groups showed significant reduction in latencies and 
path lengths over days [main effect of day, F(1, 39) = 67.62, p<0.0001, for latencies; F (1, 9) = 
25.2, p = .0007 for path lengths] (Fig. 11A, Fig. 11C). However, the low-fat diet group showed 
significant deficits in  the latency to the visible platform[main effect of diet, F(1, 39) = 12.71, p = 
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.0010] (Fig. 11A). However, there were no group differences in path lengths (Fig. 11B). There was 
a significant group difference in thigmotaxis behavior (Fig. 11D). There were no significant main 
effect differences in swimming speed, or floating over days or any group differences (Fig. 11C, 
Fig. 11E). The significantly slower latencies of the low-fat group compared to the high-fat diet 
group was associated with greater thigmotactic behavior in the low-fat diet group, suggesting low-
fat diet group could have significantly slower latencies due to increase thigmotactic behavior, 
when translated from the hidden to the visible platform training. 
During the probe trial, an unpaired t-test was conducted between feeding conditions. There 
was no preference for location, and there was no difference in performance between diets (Fig. 
12A). The low-fat diet group spent more time in thigmotaxis than the high-fat diet group t(18) = 
2.2, p = .0411 (Fig. 10D). There was no difference in thigmotaxis, path length, floating or speed 
between feeding conditions (Fig. 12B, Fig. 12C, Fig. 12E, Fig. 12F). This suggests that during the 
probe trial the low-fat diet group were exhibiting anxiety-like behavior indicated by the significant 
increase in thigmotactic behavior compared to the high-fat diet group. 
3.3.2 MWM Task (Week 8) 
Measuring latencies and path lengths during all phases of the MWM assessed cognitive 
behavior. Performance was assessed by measuring speed, thigmotaxis and floating. Each measure 
was assessed using two-way repeated measures ANOVA during the hidden and visible platform 
phase. During acquisition, all groups showed significant reduction in latencies and path lengths 
over days [main effect of day, F(6, 234) = 10.57, p<.0001, for latencies; F(6, 54) = 21.3, p<.0001 
for path lengths]. However, the low-fat diet group showed significant acquisition deficits as 
indicated by longer average latencies [main effect of diet, F(1, 39) = 25.04, p<0.0001] and path 
length average [main effect by diet, F(1, 9) = 8.46, p<0.0174] to the hidden platform, compared to 
the high-fat diet group (Fig. 13A, Fig. 13B). Furthermore, there was a significant reduction in 
swim speed over days [main effect by day, F(6, 54) = 4.193, p = .0016], and an increased floating 
across days [main effect of day, F(6, 54) = 4.328, p = .0012]. There was a decrease in thigmotaxis 
behavior over days [main effect of day F(6, 54) = 11.14, p<0.0001] (Fig. 13C, 13D, Fig. 13E). The 
low-fat diet group had higher percentage of thigmotaxis behavior [main effect of diet, F(1, 9) = 
.9.847, p = 0.0120] than the high-fat diet group (Fig. 13D). There were no significant group 
differences in floating and speed (Fig, 13C, Fig, 13E). In summary, the low-fat diet group had 
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poorer acquisition as indicated by slower latencies and longer path lengths, and this could be due 
to poor performance issues such as increase thigmotactic behavior and increase floating.  
During the visible platform test, both groups showed significant reduction in latencies and 
path lengths over days [main effect of day, F(1, 39) = 43.08, p<0.0001, for latencies; F(1, 9) = 27,p 
= .0006 for path lengths]. However, the low-fat diet group showed significant deficits in finding 
the visible platform as indicated by longer average latencies [main effect of diet, F(1, 39) = 11.02, 
p = .0020]. There were no group differences in path lengths, indicating that the low-fat mice and 
high-fat mice did not differ in this measure of swimming performance (Fig. 13A, Fig. 11B). There 
were no significant main effect differences in swimming speed, thigmotaxis, or floating over days 
(Fig. 13C, 13D, 13E). However, the low-fat diet group had a higher percentage of thigmotaxis 
behavior [main effect by diet, F(1, 9) = 13.6, p = .0050] compared to the high-fat diet group in the 
visible platform test (Fig. 13D). In summary, the low-fat diet group’s cognitive performance may 
have been associated with increased thigmotactic behavior.  
During the probe trial, there was a preference for location [main effect of location, F(1, 36) 
= 21.17, p<0001], however the low-fat diet group and the high-fat diet group did not differ in 
preference for the location during the probe trial. Using the Sidak's multiple comparisons test to 
analyze individual groups, the low-fat diet mice spent more time in the target region compared to 
non-target region t(9) = 3.771, p = .0262. The high-fat diet also mice spent more time in the target 
region compared to the non-target region t(9) = 4.232, p = .0131 (Fig. 14A). There were no 
differences in path lengths, thigmotaxis time or path scores, floating or speed between feeding 
conditions (Fig. 14B, Fig. 14C, Fig. 14D, Fig. 14E, Fig. 14F). This indicates that the high-fat diet 
group had better acquisition during the hidden platform task compared to the low-fat diet group. 
3.3.3 MWM Task (Week 13) 
Measuring latencies and path lengths during all phases of the MWM assessed cognitive 
behavior. Performance was assessed by measuring speed, thigmotaxis and floating. Each measure 
was assessed using two-way repeated measures ANOVA during the hidden and visible platform 
phase. All groups showed significant reduction in latencies and path lengths over days [main effect 
of day, F(6, 234) = 10.49, p<0.0001, for latencies; F(6, 54) = 14.76, p<0.0001 for path lengths]. 
The low-fat diet group had deficits in acquisition as indicated by higher latencies [main effect by 
diet, F(1, 39) = 16.33, p<0.0002]. In contrast, there was no group difference in path lengths (Fig. 
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15A, Fig. 15B). There an increase in thigmotaxis behavior and floating across days [main effect 
of day F(6, 54) = 2.962, p = .0142 for thigmotaxis; F(6, 54) = 5.800, p =.0001for floating], but 
there were no significant group differences in thigmotaxis and floating (Fig. 15D, Fig. 15E). There 
was no significant difference in swimming speed over days or group differences (Fig. 15C). In 
summary, the low-fat diet group had longer latencies in finding the hidden platform compared to 
high-fat diet mice. The performance effects such as increased thigmotactic behavior and floating 
across days may have confounded the low-fat diet’s deficit in latencies, an effect was not seen in 
the path length measure. 
During the visible platform test, both groups showed a significant reduction in latencies 
and path lengths over days [main effect of day, F(1, 39) = 29.93, p<0.0001, for latencies; F(1, 9) 
= 22.9, p<0.0010 for path lengths]. However, the low-fat diet group showed significant longer 
latencies to find the visible platform [main effect of diet, F(1, 39) = 6.652, p = .0138]. There were 
no group differences in path lengths (Fig. 15A, Fig. 15B). There was not a significant difference 
in the percentage of thigmotaxis behavior across days; however, the low-fat diet mice had a 
significantly higher percentage of thigmotaxis behavior [main effect by diet, F(1, 9) = 8.905, p = 
.0153] compared to the high-fat diet group in the visible platform test (Fig. 15D). There was a not 
significant increase in speed or floating across days or between feeding conditions (Fig. 15B, Fig. 
15E). In summary, the low-fat diet’s cognitive behavior could be affected by increased anxiety as 
indicated by increased thigmotactic behavior.  
During the probe trial, there was a preference for location [main effect by location, F(1, 
36) = 7.782, p = .0084]. The low-fat diet group had a significantly lower preference for the location 
[main effect of diet, F(1, 36) = 8.625, p = .0058] compared to the high-fat diet group. Using the 
Sidak’s multiple comparisons test to analyze individual groups, the low-fat diet mice spent less 
time in the target region compared to high-fat diet mice t(9) = 3.689, p = .0296. The high-fat diet 
mice spent more time in the target region compared to the non-target region t(9)  = 3.806, p = 
.0248 (Fig. 16A). The low-fat diet group spent a significantly higher percentage showing 
thigmotaxis behavior and time floating compared to the high-fat diet group [t(18) = 2.21,p = .0403, 
for thigmotaxis; t(18) = 2.152, p = .0452 for floating] (Fig. 16C, Fig. 16E).  There was no 
difference in path lengths, thigmotaxis path, and speed between feeding conditions (Fig. 16B, Fig. 
16D, Fig. 16F). In summary, the low-fat diet group showed decreased cognitive performance 
26 
 
which could be due to confounding performance issues, such as increased floating and 
thigmotactic behavior. 
3.3.4 MWM Hidden & Visual Platform (Across Group Comparison) 
A two-way repeated measures ANOVA was conducted to compare the low-fat group 
across all consumption histories. There was a significant reduction in latencies and path lengths 
over days during the hidden platform test [main effect by day, F(6, 819) = 6.916, p<0.0001 for 
latencies; F(6, 189) = 13.57, p<0.0001 for path lengths] (Fig. 17A, Fig. 17C). There was a 
significant group difference in latencies between consumption histories [main effect by 
consumption history, F(2, 819) = 14.81, p<0.0001] (Fig. 17A). This indicates that cognitive 
performance was different from each other at each time point in the low-fat diet group.  
A two-way repeated measures ANOVA was conducted to compare the low-fat group 
across all consumption histories. There was a significant reduction in latencies and path length 
over days for the visible platform test [main effect by day, F(1, 234) = 40.04, p<0.0001 for 
latencies; F(1, 54) = 25.97, p<0.0001 for path lengths] (Fig. 17A, Fig. 17C). There was a 
significant group difference in latencies between consumption histories [main effect by 
consumption history, F(2, 234) = 7.25, p = 0.0009] (Fig. 17A). This indicates that cognitive 
performance was different from each other at each time point in the low-fat diet group. 
A two-way repeated measures ANOVA was conducted to compare the high-fat group 
across all consumption histories. There was a significant reduction in latencies and path lengths 
over days during the hidden platform test [main effect by day, F(6, 819) = 22.14, p<0.0001 for 
latencies; F(6, 189) = 17.15, p<0.001 for path lengths] (Fig. 17B, Fig. 17D). There was a 
significant group difference in latencies between consumption histories [main effect by 
consumption history, F(2, 819) = 22.39, p<0.0001] (Fig. 17B). This indicates that cognitive 
performance was different from each other at each time point in the high-fat diet group. 
A two-way repeated measures ANOVA was conducted to compare the high-fat group 
across all consumption histories. There was a significant reduction in latencies and path lengths 
over days for the visible platform test [main effect by day, F(1, 234) = 29.82, p<0.0001 for 
latencies; F(1,54) = 28.24, p<0.001] (Fig. 17B, Fig. 17D). There was a significant group difference 
between consumption histories [main effect by consumption history, F(2, 234) = 7.25, p = 0.0009] 
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(Fig. 17B). This indicates that cognitive performance was different from each other at each time 
point in the high-fat diet group. 
3.3.5 MWM Probe Trial (Across Group Comparison) 
A preference score was conducted during the probe trial. There was a significant difference 
in preference for the target region between consumption histories [main effect by consumption 
history, F(2, 54) = 5.825, p = 0.0051]. There was not a significant difference in preference for the 
target region between feeding conditions [main effect by feeding condition, F(1, 54) = 2.286, p = 
0.1364] (Fig. 17E). This indicates that acquisition to the platform differed in preference between 
consumption history groups, but did not differ between feeding conditions. 
3.4 Forced Swim Test 
3.4.1 Immobility measure 
An unpaired t-test was conducted to measure immobility between the feeding conditions. 
On average, groups with 3 weeks of consumption history, the low-fat diet group spent less time 
immobile compared to the high-fat diet group t(18) = 2.261, p = .0364 (Fig. 18A). On average 
groups with 8 weeks of consumption history, there was no significant difference in time spent 
immobile between the low-fat diet group and the high-fat diet group (Fig. 18B). On average, 
groups with 13 weeks of consumption history, there was no significant difference in time spent 
immobile between the low-fat diet group and the high-fat diet group (Fig. 18C). This indicates that 
only at 3 week there was a significant difference between feeding conditions, and no differences 
at the 8 week and 13 week group.  
An unpaired t-test was conducted to measure immobility between consumption history 
groups. There was no difference in immobility time across consumption histories or between 
feeding conditions (Fig. 19A, Fig. 19B). This indicates that there was no difference in immobility 
time between consumption history groups. 
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3.5 Correlational Data 
3.5.1 Weights 
In the 3-week group, there was a negative correlation between weight and total distance in 
the low-fat diet group (r(8) = -.776, p = .008) (Table 1). In the 8-week group, there was a negative 
correlation between weight and entry total in the low-fat diet group (r(8) = -.746, p = .013 (Table 
2). There were no significant correlations between body weight and behavioral tasks measured in 
the 13-week group (Table 3). This indicates that in the low-fat diet group, as increased weight 
occurred, there was a decrease in general locomotor activity from the EPM and OF test. 
3.6 Weights 
3.6.1 Body weight 
An unpaired t-test was conducted to measure difference in weight between the feeding 
conditions. In the 3-week group, the high-fat diet group was significantly higher in weight 
compared to the low-fat diet group on Day 11 t(9) = 7.302, p<.0001 (Fig. 19A). In the 8-week 
group, the high-fat group was significantly higher in weight compared to the low-fat diet group on 
Day 1 t(9) = 8.787, p<.0001, and Day 12 t(9) = 8.787, p<.0001 (Fig. 19A, Fig. 19B). In the 13-
week group, the high-fat diet group had a significantly higher weight than the low-fat diet group 
on Day 1 t(9) = 8.686, p<.0001, Day 3 t(9) = 8.686, p<.0001, and Day 9 t(9) = 8.686, p<.0001. 
This indicates that the high-fat diet group has been statistically higher in weight compared to the 
low-fat diet group in all consumption history groups. 
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CHAPTER 4 DISCUSSION 
The first aim of this study was to assess the cognitive and behavioral consequences of 
various histories of high-fat diet consumption. I hypothesized that increased high-fat consumption 
would increase cognitive impairment and behavioral dysregulation, and that these impairments 
would worsen over weeks of high-fat diet consumption. My second aim was to investigate 
cholesterol levels in the brain as a consequence of a high-fat diet consumption, and if cholesterol 
accumulation in the brain was due to de novo synthesis. Analysis of cholesterol in the brain is still 
a work in progress in Dr. Elmendorf’s lab. I hypothesized that brain cholesterol levels will increase 
with longer consumption durations in vulnerable areas such as the hippocampus, cerebral cortices 
and cerebellum. 
4.1 Main Findings 
Consumption of the experimental specialty diets produced a number of significant 
behavioral effects. These significant effects began to emerge after only 3 weeks of low-and high-
fat feeding. During the acquisition phase of the MWM task, there was a significant reduction in 
latency and path lengths to the hidden platform across days, indicating the mice were learning the 
location of the hidden platform. However, low-fat and high-fat fed mice did not differ in these 
parameters. There was a significant difference in feeding condition during the MWM visible 
platform task, with the low-fat diet group displaying a significantly higher latencies to find the 
platform, thigmotactic behavior was also higher in the low-fat diet group. There was no difference 
in path lengths between feeding conditions. These collective results suggest that differences seen 
in low-fat latencies were likely due to thigmotactic behavior and not cognitive impairment. In 
terms of behavioral dysregulation, the high-fat diet group had higher time spent immobile, 
indicating they are expressing depression-like symptoms to a greater degree than the low-fat fed 
mice.   
After 8 weeks of high-fat feeding, there was a reduction in locomotor activity in the OF. 
In the MWM, all measures exhibited changes across days; i.e., reduction in latencies and path 
lengths for cognitive assessment, and an increase in speed, thigmotaxis behavior, and floating for 
performance measures. Between feeding conditions, the low-fat diet group actually exhibited 
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greater deficits as indicated by higher latencies, path lengths. This pattern was similar in the visible 
platform test for latencies. Similar to that observed after 3 weeks of specialty diet consumption, 
the low-fat diet group had significantly higher thigmotactic behavior in both the visible and hidden 
platform task. Performance measures such as thigmotactic behavior may confound cognitive 
measures since latencies and path lengths rely on the mouse to explore the pool and reach the 
platform. Since the low-fat diet mouse is exhibiting anxiety-like behavior, they are swimming just 
in the outer regions of the pool, which looks like cognitive impairment due to higher latencies and 
path lengths. This makes cognitive performance measures for latency and path lengths 
uninterruptable. During the probe trial there was a significant preference for the target region 
compared to the non-target group in both the low-fat diet group and the high-fat diet groups, but 
there was no significant difference between feeding conditions. 
After 13 weeks of high- or low-fat feeding, the main findings in OF showed that the low-
fat diet group traveled further than the high-fat diet group, indicating they had more general 
locomotor activity. Furthermore, low-fat fed mice spent more time in, and traveled more in the 
center compared to the high-fat diet group, suggesting that the high-fat diet group could be 
expressing anxiety-like symptoms (thigmotaxis). In the MWM task, there was an overall reduction 
in latencies, and path lengths (cognitive measures), and an increase in speed, thigmotaxis behavior, 
and floating in performance measures across days. The low-fat diet group had exhibited higher 
latencies and thigmotaxis behavior in both the hidden and visible platform test. During the probe 
trial, the low-fat diet group also had increased floating and thigmotaxis behavior, suggesting 
possible fatigue or anxiety could be affecting their performance. There was also a preference for 
the target region, with the high-fat diet group exhibiting higher preference score. 
4.2 EPM 
The EPM task is a staple tool for assessing anxiety-like behavior in rodents. Yet, published 
data assessing anxiety-like behavior after high-fat consumption is limited. One study assesses such 
anxiety-like behavior using the OF and Zero Maze Test apparatuses (Gainey et al., 2016). They 
found elevated anxiety-like symptoms after 6 weeks of diet consumption. However, there were no 
differences between the high- and low-fat feeding conditions. We found a significant decrease in 
time and entries into the open arms of the EMP with increased consumption history. However, this 
may not be due to high-fat consumption per se, but instead to isolation since we single house our 
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6N mice. We single housed our mice for such studies because social hierarchy in rodents shows 
the subordinate rodent will eat less food than the dominant one (Davis, 1953). Therefore, this may 
affect physiological changes seen with high-fat consumption, and subsequence cognitive and 
behavioral performance. Several studies have shown that single housing can reduce the number of 
entries and time spent in the EPM open arms (Hunt & Hambley, 2006; Walf & Frye, 2007; Zhu et 
al., 2006). Therefore, in sum, our data likely demonstrate the negative effects of isolation instead 
of high-fat consumption. 
4.3 Open Field Test 
The OF is another assessment tool for assessing anxiety-like symptoms, as well as general 
locomotor activity. At 13 weeks, our data reflected reduced time and distance spent in the center 
(thigmotaxis) in the high-fat diet group, which is nearly double the time course found from the OF 
study done by Gainey et al. (2016). This suggests that there could be strain differences in 
performance since Gainey et al. (2016) used 6J mice. Isolation effects may also have been present 
in this behavioral measure too as our results showed a decrease in locomotor activity and time 
spent in the center. Similar to the EPM, single housing mice for a long duration will reduce general 
locomotor activity and time spent in the center (Hunt & Hambley, 2006; Walf & Frye, 2007; Zhu 
et al., 2006). Thus, single housing would appear to be an important issue to consider for future 
studies as it is a confounding variable that limits our interpretation of a high-fat consumption 
effects on anxiety. 
4.4 MWM 
The MWM is a common assessment task for investigating the relationship between 
cognitive impairment and a high-fat consumption. There are numerous articles reporting that a 
high-fat diet is associated with a cognitive impairment in this task, but a majority of these studies 
were performed with rats. Limited mouse model data show deficits from high-fat diets in the range 
of 60%. We assessed cognitive impairment at fat percentages at 10% and 45%, which are much 
lower than previous studies (Arnold et al., 2015; Gainey et al., 2016; Kleine et al., 2016). In our 
study, cognitive assessment (latencies and path lengths) could not be interpreted due to 
performance issues, including floating and thigmotactic behavior with increased days. These 
performance issues could be a result of performance fatigue, anxiety or increased stress due to 
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long-term single housing. The increase floating and thigmotactic behavior was highest near the 
last few days of the 9-day behavioral experiment, providing evidence for performance fatigue and 
anxiety behavior. Also, the effects appeared to worsen with greater durations of consumption.  
The low-fat diet group exhibited more anxiety-like symptoms compared to the high-fat diet 
group as indicated by increased thigmotactic behavior. This ultimately led to an increased latencies 
and path lengths during cognitive assessment of behavioral testing since the mice spent more time 
in outer areas of the pool vs searching for the platform, therefore making assessment 
uninterpretable. This was in opposition to our hypothesis which was the LF diet group would 
exhibit lower negative behavioral affect compared to the high-fat diet group. Assessment of 
another cognitive behavioral task that will lead to less negative behavioral affect is recommended 
to properly assess cognitive symptoms. Therefore, In sum, this experiment was ultimately unable 
to assess high-fat diet induced cognitive impairment due to this performance issues.  
4.5 Forced Swim Test 
The FS test is a common measure of depressive-like behavior. There is little data 
addressing the potential relationship between a high-fat diet and depressive-like behavior. The 
current project showed that there was only a difference in FS immobility between the low-fat and 
high-fat diet group at week 3. This difference was not seen in week 8 and 13, which is in the 
opposite direction of my hypothesis. However, because this experiment took place immediately 
after the MWM task, it may have been possible that carryover effects of floating seen in last days 
of MWM influence the FS behavior. In other words, the floating behavior that developed in the 
MWM task may have ended up manifesting again in the FS task. Furthermore, the mice may have 
developed a conditioned response to the researcher, learning that they would be rescued from the 
water after a certain amount of time, again influencing willingness to simply float. Therefore, the 
behavior despair that we were attempting to measure may have been compromised by the previous 
MWM testing. Finally, according to Petit-Demouliere, Chenu, & Bourin, (2005), single housed 
mice tend to exhibit greater immobility compared to group house mice. All in all, the order of 
behavioral testing, and our decision to single house the mice may have confounded our FS test 
data.  
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4.6 Weights 
In all groups, there was a consistent pattern of the high-fat diet groups weighing statistically 
more than the low-fat diet group. This is a significant factor to acknowledge since body weight 
could affect performance in any of the behavioral studies. There was a negative correlation in the 
low-fat diet group, indicating as weight increased, there was a decrease in general locomotor 
activity at week 3 and week 8. Interestingly, this was not true for the high-fat diet group at any 
consumption history time point. The higher body weight may have been protective from the cold 
temperature in the Morris Water Maze due to insulation. All in all, the increased body weight 
difference in the high-fat diet group is an important factor to consider when evaluating the 
behavioral tests. 
4.7 Brain Cholesterol 
This study will examine brain cholesterol levels in the cerebral cortices, hippocampi and 
cerebellum. I hypothesize that vulnerable brain regions such as the cerebral cortices and 
hippocampi will have elevated brain cholesterol levels; whereas, the cerebellum will have no 
changes in cholesterol levels. Brain regions’ cholesterol levels will be determined via between-
groups analysis among feeding conditions and consumption history groups. There will also be a 
Pearson’s correlation to see if there are any correlations between cholesterol levels and behavioral 
tasks. All in all, cholesterol level analysis is an important part of this project since it bridges the 
underlying physiological mechanism with the cognitive and behavioral performance. Furthermore, 
this data will allow us to see the progression of cholesterol levels with increased consumption 
duration. 
4.8 Future Research 
This project has given greater insight into the behavior consequences of high-fat 
consumption. Due to the limited assessment of a high-fat diet mouse model, standardization of 
specific aspects in the design can be beneficial to understanding the consequences of the specialty 
diet consumption. For example, our standardizing the percentage of saturated fat to be reflective 
of Western society was aimed to provide us insight into relevant negative consequences of 
overeating as seen in our society. Unfortunately, there have only been assessments in the upper 
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region of 60% (Arnold et al., 2015; Gainey et al., 2016; Kleine et al., 2016). Our project utilized a 
low-fat diet (10%) and a high-fat diet (45%), which is akin to that eaten in more metabolically 
healthy and non-healthy individuals, respectively. An unexpected result was the low-fat diet 
group’s performance in the MWM, in which they performed worse than the high-fat diet group. 
Certain controls such as the inclusion of a standard mouse chow (4.5% crude fat) group could give 
us insight into what behavior looks like in 6N mice in the absence of any diet manipulation. This 
could tell us if the low-fat diet group is considered a form of “high-fat” diet and is equally affecting 
performance as the high-fat (45%) diet group. Another control group that could be beneficial is a 
group reflective of a normal Western diet (33%) (National Center for Health Statistics, 2017). 
Another aspect of the current study that was not standardized was age group; a majority of high-
fat diet studies have investigated older populations, as they tend to be vulnerable to manipulation 
of diet. Age is an important component since is it a confounding variable when assessing cognitive 
performance, so standardizing a mouse model reflective of a normal adult population is essential. 
Biological sex is another factor to consider as behavioral measurements such as the FS test indicate 
that females have shorter immobility time (Petit-Demouliere, Chenu, & Bourin, 2005). 
Due to performance issue such as fatigue and anxiety in the MWM task, we were unable 
to clearly interpret the cognitive aspects of the behavior. Utilization of a behavior with a task that 
do not require multiple days or placing them in a stressful environment such in a pool of water 
could help alleviate performance fatigue. An alternative cognitive task that has been used to assess 
the relationship between high-fat diet and cognitive impairment is the NOR task. This is a 
compound behavioral task that is able to assess multiple brain regions and does not require any 
physical stamina (Cordner & Tamashiro, 2015). In conclusion, a standardized mouse model is 
essential for determining the behavioral consequences of a high-fat consumption. 
4.9 Conclusion 
This study allowed us to analyze the gaps in the literature about the effects due to chronic 
consumption of a high-fat diet. The most robust data came from analyzing the consumption 
histories and the progression of cognitive and behavioral dysfunction. The 8 week group appeared 
to exhibit the most anxiety-like behavior in the high-fat group in the EMP and OF, and the low-fat 
diet group showed increased thigmotactic behavior in the MWM at this time point. The symptoms 
were less detrimental at 13 weeks, indicating some form of adaptation. We also were able to see 
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the progression of isolation effects in the EMP and OF test due to single housing the mice. So, 
future research should weigh the risks and benefits of isolation effects and dominance that may 
affect food consumption. Another key finding in this study was in anxiety measurements in EPM, 
OF and MWM. Anxiety was a major confound in the MWM that made cognitive performance 
uninterruptable. All in all, this study allowed us to get insight into various factors and fill the gaps 
in the literature of the effects of chronic consumption of a high-fat diet. 
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FIGURES 
 
 
 
 
 
 
Figure 1. Proposed HBP pathway to insulin resistance 
 
 
 
 
 
 
37 
 
 
 
 
 
 
 
 
 
 
Figure 2. Pathway to cholesterol biosynthesis 
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Figure 3. Elevated Plus Maze (Week 3) 
A comparison of EPM entries and time in the open and closed arms between the 
low-fat diet group and high-fat diet group was assessed with the 3 weeks of 
consumption history group. 
 
 
 
 
lo
w
hi
gh
0
5
10
15
20
E
n
tr
ie
s
Open Arm Entries
Low high
0
50
100
150
200
250
300
T
im
e
 (
s
e
c
)
Open Arm Time
lo
w
hi
gh
0
5
10
15
20
E
n
tr
ie
s
Closed Arm Entries
Low high
0
50
100
150
200
250
300
T
im
e
 (
s
e
c
)
Closed Arm Time
A B
C D
low
high
n=10
n=10
Elevated Plus Maze (Week 3) 
39 
 
 
 
 
 
 
 
 
 
 
Figure 4. Elevated Plus Maze (Week 8) 
A comparison of EPM entries and time in the open and closed arms between the low-fat 
diet group and high-fat diet group was assessed with the 8 weeks of consumption history 
group. 
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Figure 5. Elevated Plus Maze (Week 13) 
A comparison of EPM entries and time in the open and closed arms between the low-fat 
diet group and high-fat diet group was assessed with the 13 weeks of consumption history 
group. 
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Figure 6. Elevated Plus Maze (Across Group Comparison) 
A comparison of EPM entries and time in the open arm was assessed across all 
consumption history groups. 
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Figure 7. Open Field Test (Week 3) 
In the OF, a comparison of total distance, center distance, percentage distance spent in 
center, center time and percentage time spent in center were assessed between the low-fat 
diet and high-fat diet group with a 3-week consumption history. 
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Figure 8. Open Field Test (Week 8) 
In the OF, a comparison of total distance, center distance, percentage distance spent in 
center, center time and percentage time spent in center was assessed between the low-fat 
diet and high-fat diet group with an 8-week consumption history. 
 
Total Distance High vs Low Fat Diet
lo
w
hi
gh
0
2000
4000
6000
Specialty Diet
D
is
ta
n
c
e
 t
ra
v
e
le
d
 (
c
m
)
*
Center Distance
lo
w
hi
gh
0
500
1000
1500
Specialty Diet
D
is
ta
n
c
e
 t
ra
v
e
le
d
 (
c
m
)
Center TIme
lo
w
hi
gh
0
100
200
300
Specialty Diet
T
im
e
 (
s
e
c
)
% Center Distance
lo
w
hi
gh
0
20
40
60
80
100
Specialty Diet
D
is
ta
n
c
e
 t
ra
v
e
le
d
 (
c
m
)
% Center Time
lo
w
hi
gh
0
10
20
30
40
50
Specialty Diet
P
e
rc
e
n
ta
g
e
low
high
A
B
D
C
E
n=10
n=10
Open Field Test (Week 8) 
44 
 
 
 
 
 
 
 
 
 
 
Figure 9. Open Field Test (Week 13) 
In the OF, a comparison of total distance, center distance, percentage distance spent in 
center, center time and percentage time spent in center was assessed between the low-fat 
diet group and high-fat diet group with a 13-week consumption history. 
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Figure 10. Open Field Test (Across Group Comparison) 
In the OF,  a comparison of total distance, center distance and center time was assessed 
across consumption history groups. 
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Figure 11. Morris Water Maze (Week 3) 
During the Hidden and Visual Platform phase of the MWM, a comparison of lantecy, 
speed, path lengths, thigmotaxis, and floating were assessed between the low-fat diet and 
high-fat diet group in the 3 week group. 
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Figure 12. Morris Water Maze-Probe Trial (Week 3) 
During the Probe trial of the MWM, a comparison of time (preference in target region), 
path lengths, thigmotaxis time, thigmotaxis path lengths, floating, and speed were assessed 
between the low-fat diet and high-fat diet group in the 3 week group. 
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Figure 13. Morris Water Maze (Week 8) 
During the Hidden and Visual Platform of the MWM, a comparison of lantecy, speed, path 
lengths, thigmotaxis, and floating were assessed between the low-fat diet and high-fat diet 
group in the 8 week group. 
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Figure 14. Morris Water Maze-Probe Trial (Week 8) 
During the Probe Trial of the MWM, a comparison of time (preference in target region), 
path lengths, thigmotaxis time, thigmotaxis path lengths, floating, and speed were assessed 
between the low-fat diet and high-fat diet group in the 8 week group 
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Figure 15. Morris Water Maze (Week 13) 
During the Hidden and Visual Platform of the MWM, a comparison of lantecy, speed, path 
lengths, thigmotaxis, and floating were assessed between the low-fat diet and high-fat diet 
group in the 13 week group. 
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Figure 16. Morris Water Maze-Probe Trial (Week 13) 
During the Probe Trial of the MWM, a comparison of time (preference in target region), 
path lengths, thigmotaxis time, thigmotaxis path lengths, floating, and speed were assessed 
between the low-fat diet and high-fat diet group in the 13 week group. 
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Figure 17. Morris Water Maze (Across Group Comparison) 
A comparison of latencies were assess between consumption history groups during the 
hidden and visual platform test from the MWM. Preference scores for target region was 
measured during the probe trial of the MWM. 
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Figure 18. Forced Swim Test (Week 3, 8, 13) 
In all consumption history groups, comparison of immobility time between the low-fat diet 
group and high-fat diet group were assess during the FS. 
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Figure 19. Forced Swim Test (Across Group Comparison) 
Comparison of immobility time across consumption history groups was assessed in both 
the low-fat diet and the high-fat diet group during the FS. 
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Figure 20. Body Weight (Week 3, 8 & 13) 
Body weight of low-fat and high-fat diet mice during the behavioral experiment phase 
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Table 1. Week 3 Correlations: Weight & Behavioral Tasks 
 
 
 
 
 
 
 
 
 
 
 
EPM Ent_CA EPM Ent_OA EPMEnt_Total EPM Ent_CA_Pct EPM Ent_OA_Pct EPM Time_CA EPM Time_OA OF TotDist OF CtrDist OF CtrDist_Pct
Weight 3Wk LF Pearson 
Correlation
0.039 -0.110 -0.058 0.109 -0.110 -0.207 0.040 -.776
** -0.502 -0.300
Sig. (2-
tailed)
0.915 0.762 0.873 0.764 0.763 0.567 0.913 0.008 0.139 0.400
N 10 10 10 10 10 10 10 10 10 10
Weight 3WK HF Pearson 
Correlation
-0.505 0.211 -0.393 -0.423 0.423 -0.394 0.324 -0.517 -0.165 -0.257
Sig. (2-
tailed)
0.136 0.558 0.261 0.223 0.223 0.260 0.361 0.126 0.648 0.474
N 10 10 10 10 10 10 10 10 10 10
 OF CtrTime OF CtrTime_Pct MWM time MWM dist PRB TIMETarget MWMVis time MWMVis dist MWM SPD MWMVis SPD MWM THG
Weight 3Wk LF Pearson 
Correlation
0.094 0.094 -0.139 0.489 0.069 -0.231 -0.086 -0.428 0.307 0.588
Sig. (2-
tailed)
0.797 0.797 0.703 0.151 0.850 0.521 0.813 0.217 0.388 0.074
N 10 10 10 10 10 10 10 10 10 10
Weight 3WK HF Pearson 
Correlation
-0.058 -0.058 0.322 0.534 0.521 0.300 0.352 -0.159 -0.328 0.483
Sig. (2-
tailed)
0.873 0.873 0.364 0.112 0.122 0.400 0.319 0.661 0.355 0.157
N 10 10 10 10 10 10 10 10 10
MWMVis THG MWM FLT MWMVis FLT PRB SPD PRB FLT PRB THGTime PRB THGPTH PRB TimeNonTarget PRB Dist FS Immob
Weight 3Wk LF Pearson 
Correlation
-0.401 -0.315 -0.424 -0.061 0.109 0.068 -0.002 0.120 -0.059 -0.329
Sig. (2-
tailed)
0.251 0.376 0.222 0.866 0.764 0.852 0.995 0.741 0.870 0.354
N 10 10 10 10 10 10 10 10 10 10
Weight 3WK HF Pearson 
Correlation
0.215 0.471 0.242 -0.411 0.419 0.025 0.095 0.359 -0.402 0.006
Sig. (2-
tailed)
0.550 0.170 0.500 0.238 0.229 0.945 0.794 0.308 0.250 0.986
N 10 10 10 10 10 10 10 10 10 10
Week 3 Correlations: Weight & behavioral tasks
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Table 2. Week 8 Correlations: Weight & Behavioral Tasks 
 
 
 
 
 
 
 
 
 
 
 
EPM Ent_CA EPM Ent_OA EPMEnt_Total EPM Ent_CA_Pct EPM Ent_OA_Pct EPM Time_CA EPM Time_OA OF TotDist OF CtrDist OF CtrDist_Pct
Weight 8WK LF Pearson 
Correlation
-0.630 -0.562 -0.746* -0.127 0.126 -0.322 0.256 -0.509 -0.278 -0.184
Sig. (2-
tailed)
0.051 0.091 0.013 0.727 0.728 0.365 0.475 0.133 0.436 0.612
N 10 10 10 10 10 10 10 10 10 10
Weight 8Wk HF Pearson 
Correlation
-0.365 0.372 -0.089 -0.361 0.361 -0.355 0.439 0.248 0.106 0.117
Sig. (2-
tailed)
0.299 0.289 0.807 0.306 0.306 0.315 0.204 0.489 0.771 0.747
N 10 10 10 10 10 10 10 10 10 10
 OF CtrTime OF CtrTime_Pct MWM time MWM dist PRB TIMETarget MWMVis time MWMVis dist MWM SPD MWMVis SPD MWM THG
Weight 8WK LF Pearson 
Correlation
-0.353 -0.353 -0.161 -0.016 0.088 -0.058 0.377 0.154 0.419 -0.124
Sig. (2-
tailed)
0.317 0.317 0.658 0.965 0.809 0.873 0.283 0.671 0.228 0.733
N 10 10 10 10 10 10 10 10 10 10
Weight 8Wk HF Pearson 
Correlation
0.237 0.237 0.096 0.077 -0.023 -0.267 -0.343 -0.098 -0.213 -0.485
Sig. (2-
tailed)
0.510 0.510 0.792 0.832 0.951 0.456 0.331 0.789 0.556 0.155
N 10 10 10 10 10 10 10 10 10 10
MWMVis THG MWM FLT MWMVis FLT PRB SPD PRB FLT PRB THGTime PRB THGPTH PRB TimeNonTarget PRB Dist FS Immob
Weight 8WK LF Pearson 
Correlation
-0.210 -0.175 -0.361 -0.012 -0.130 -0.113 -0.126 -0.155 0.031 0.276
Sig. (2-
tailed)
0.561 0.628 0.305 0.974 0.720 0.755 0.729 0.670 0.933 0.439
N 10 10 10 10 10 10 10 10 10 10
Pearson 
Correlation
-0.247 -0.340 0.188 -0.237 0.395 -0.075 -0.224 -0.102 -0.258 -0.328
Sig. (2-
tailed)
0.491 0.336 0.602 0.510 0.258 0.837 0.534 0.778 0.471 0.355
N 10 10 10 10 10 10 10 10 10 10
Week 8 Correlations: Weight & behavioral tasks
Weight 8Wk HF
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Table 3. Week 13 Correlations: Weight & Behavioral Tasks 
 
 
 
 
 
 
 
 
 
 
 
 
EPM Ent_CA EPM Ent_OA EPMEnt_Total EPM Ent_CA_Pct EPM Ent_OA_Pct EPM Time_CA EPM Time_OA OF TotDist OF CtrDist OF CtrDist_Pct
Weight 13WK LF Pearson 
Correlation
0.112 -0.583 -0.448 0.603 -0.603 0.321 -0.455 -0.517 -0.594 -0.629
Sig. (2-
tailed)
0.759 0.077 0.194 0.065 0.065 0.366 0.186 0.126 0.070 0.051
N 10 10 10 10 10 10 10 10 10 10
Weight 13WK HF Pearson 
Correlation
0.401 -0.065 0.254 0.168 -0.168 0.205 -0.221 0.422 0.299 0.407
Sig. (2-
tailed)
0.251 0.859 0.479 0.642 0.642 0.571 0.539 0.224 0.401 0.244
N 10 10 10 10 10 10 10 10 10 10
 OF CtrTime OF CtrTime_Pct MWM time MWM dist PRB TIMETarget MWMVis time MWMVis dist MWM SPD MWMVis SPD MWM THG
Weight 13WK LF Pearson 
Correlation
-.677
*
-.677
* -0.133 0.060 0.236 -0.183 -0.122 0.203 0.163 -0.036
Sig. (2-
tailed)
0.032 0.032 0.714 0.869 0.511 0.612 0.736 0.574 0.652 0.921
N 10 10 10 10 10 10 10 10 10 10
Weight 13WK HF Pearson 
Correlation
0.341 0.341 0.392 -0.023 -0.179 0.125 -0.053 -0.452 -0.489 0.534
Sig. (2-
tailed)
0.335 0.335 0.263 0.950 0.621 0.731 0.885 0.190 0.151 0.112
N 10 10 10 10 10 10 10 10 10 10
MWMVis THG MWM FLT MWMVis FLT PRB SPD PRB FLT PRB THGTime PRB THGPTH PRB TimeNonTarget PRB Dist FS Immob
Pearson 
Correlation
-0.303 -0.067 -0.125 0.147 -0.030 -0.177 0.032 0.245 0.130 0.455
Sig. (2-
tailed)
0.395 0.854 0.731 0.685 0.934 0.625 0.930 0.495 0.720 0.187
N 10 10 10 10 10 10 10 10 10 10
Pearson 
Correlation
0.231 0.485 0.494 -0.476 0.424 0.413 0.370 0.252 -0.446 -0.391
Sig. (2-
tailed)
0.521 0.156 0.147 0.165 0.223 0.236 0.293 0.483 0.196 0.264
N 10 10 10 10 10 10 10 10 10 10
Week 13 Correlations: Weight & behavioral tasks
Weight 13WK LF
Weight 13WK HF
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